Latest Price Targets from the World's Best Analysts & Research Firms

#	Analyst & Firm	Stock	Price	Price Target	Upside Downside	Rating	Date
10951	BOAS 10951 B of A Securities Jason Gerberry	Liquidia Corp LQDA $2.48B	$28.85	$23	20% downside	Buy	2 months ago
10952	M 10952 Mizuho Gregg Moskowitz	SAIL SailPoint, Inc. Common Stock SAIL $12.2B	$21.98	$26	18% upside	Neutral	2 months ago
10953	GS 10953 Goldman Sachs Bonnie Herzog	Casey's General Stores CASY $18.8B	$505.64	$450	11% downside	Neutral	2 months ago
10954	PS 10954 Piper Sandler Alex Potter	Tesla TSLA $1.13T	$350.84	$400	14% upside	Overweight	2 months ago
10955	PS 10955 Piper Sandler Brian Mullan	Dave & Buster's PLAY $820M	$23.73	$30	26% upside	Neutral	2 months ago
10956	PS 10956 Piper Sandler Michael Lavery	Post Holdings POST $5.88B	$108.29	$150	39% upside	Overweight	2 months ago
10957	BC 10957 BMO Capital Andrew Strelzik	Dave & Buster's PLAY $820M	$23.73	$35	47% upside	Outperform	2 months ago
10958	BC 10958 BMO Capital Kelly Bania	Casey's General Stores CASY $18.8B	$505.64	$515	2% upside	Market Perform	2 months ago
10959	RJ 10959 Raymond James Michael Freeman	Wave Life Sciences WVE $1.32B	$8.29	$14	69% upside	Outperform	2 months ago
10960	RJ 10960 Raymond James Michael Freeman	TECX Tectonic Therapeutic, Inc. Common Stock TECX $314M	$16.80	$76	352% upside	Outperform	2 months ago
10961	RJ 10961 Raymond James Michael Freeman	Dyne Therapeutics DYN $2.02B	$14.22	$37	160% upside	Outperform	2 months ago
10962	RJ 10962 Raymond James Michael Freeman	Disc Medicine IRON $2.11B	$60.76	$89	46% upside	Strong Buy	2 months ago
10963	RJ 10963 Raymond James Michael Freeman	Avidity Biosciences RNA $6.48B	$50.36	$65	29% upside	Strong Buy	2 months ago
10964	M 10964 Mizuho Matthew Broome	Palantir PLTR $363B	$153.11	$116	24% downside	Underperform	2 months ago
10965	S 10965 Stifel Alex Thompson	Cullinan Oncology CGEM $413M	$6.99	$22	215% upside	Buy	2 months ago
10966	RC 10966 RBC Capital Mike Dahl	Core & Main CNM $12.7B	$66.98	$67	0% upside	Outperform	2 months ago
10967	C 10967 Citigroup Alastair Syme	ConocoPhillips COP $116B	$92.95	$115	24% upside	Buy	2 months ago
10968	O 10968 Oppenheimer Scott Schneeberger	QXO QXO Inc QXO $14.9B	$22.05	$27	22% upside	Outperform	2 months ago
10969	O 10969 Oppenheimer Brian Schwartz	Clearwater Analytics CWAN $6.07B	$20.77	$36	73% upside	Outperform	2 months ago
10970	NCM 10970 Northland Capital Markets	VENU Venu Holding Corporation VENU $512M	$11.76	$15	28% upside	Outperform	2 months ago
10971	MS 10971 Morgan Stanley Simeon Gutman	Academy Sports + Outdoors ASO $3.39B	$50.86	$52	2% upside	Equal-Weight	2 months ago
10972	C 10972 Citigroup Carly Kenselaar	Travere Therapeutics TVTX $1.93B	$21.64	$32	48% upside	Buy	2 months ago
10973	MS 10973 Morgan Stanley Sanjit Singh	GitLab GTLB $7.63B	$45.73	$56	22% upside	Overweight	2 months ago
10974	C 10974 Citigroup Thomas Palmer	J.M. Smucker SJM $12B	$112.51	$118	5% upside	Buy	2 months ago
10975	MS 10975 Morgan Stanley Craig Hettenbach	Hims & Hers Health HIMS $10.9B	$48.41	$40	17% downside	Equal-Weight	2 months ago